PipelBiz

An equity crowdfunding platform connecting small businesses with investors in Israel.

Crowdfunding Active Tel Aviv-Yafo, Israel Est. 2015
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
16
in our dataset
Rounds participated
16
Rounds led
4
Rounds' value
$4.6M
total disclosed, rounds participated
Stages
A Round, Seed, Pre-Seed

About

PipelBiz is an Israeli equity crowdfunding platform that enables individuals to invest in growing companies, including startups in various fields like medicine, high-tech, internet, and cannabis, as well as real estate projects. The platform aims to democratize investment opportunities, allowing non-accredited investors to participate in the 'Start-Up Nation' and reduce reliance on foreign investors. PipelBiz also invests in every company featured on its platform under the same terms as the crowd investors.

Portfolio · 16

CuratioDL
Deep-learning-based Cancer Management Solutions
Led ★ 1 round $317K committed Latest: 2022-12
AvoMed
Biowaste-based Bioactive Compound for Dermal Disorders
Led ★ 1 round Latest: 2022-08
OTTek
Colonoscopy Assist Device
1 round $406K committed Latest: 2022-03
iSite
Personal Space Digitizer for Construction Workers
1 round $492K committed Latest: 2022-03
Laser Beam Therapeutics
Laser Therapy Solutions
1 round $330K committed Latest: 2020-01
Findodo
AI-based Gift Discovery
Led ★ 1 round $450K committed Latest: 2019-10
BEAM Travel Technology
AI-based Social Trip-planning Platform
1 round $500K committed Latest: 2019-08
Striker
Developing an app for youth soccer players, coaches, and recruiters.
1 round Latest: 2019-02
VivoText
Digital Voice-cloning Platform
1 round $250K committed Latest: 2017-12
OurLend
P2P Loan Platform
Led ★ 1 round $322K committed Latest: 2017-11
LessForMe
Advertising Commission Referral Platform
1 round $110K committed Latest: 2017-07
Doublx
Virtual Tours for Real Estate
1 round $100K committed Latest: 2017-03
Museloop
Mobile App to Engage Museum Visitors
1 round $116K committed Latest: 2017-02
Rootstock
Cooperative Product-delivery Service for Communities
1 round $41K committed Latest: 2017-01
Frank
Online Survey Platform
1 round $45K committed Latest: 2016-06
Build-e
B2B Marketplace for the Construction Industry
1 round $1.1M committed Latest: 2015-08

Investment activity

7 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences28
Business Software11
Industrial Technologies6
Agriculture & Food Technologies6
Fintech & Insurtech6
Media & Entertainment Technologies6
Aerospace, Defense & HLS3
Automotive & Mobility Technologies3

Q&A

What is PipelBiz's primary investment focus?
PipelBiz is an equity crowdfunding platform that matches small businesses with investors, aiming to help entrepreneurs start businesses with minimal initial seed and maximum equity.
Which sectors does PipelBiz primarily invest in?
PipelBiz shows a strong concentration in Health Tech & Life Sciences, with 28 portfolio companies, and Business Software, with 11 portfolio companies. Other notable sectors include Agriculture & Food Technologies, Industrial Technologies, Fintech & Insurtech, and Media & Entertainment Technologies.
Can you name some of PipelBiz's recent exits?
In May 2026, PipelBiz saw an acquisition exit for Bit2c by eToro, and Bridgify was acquired by HBX Group. In June 2024, Solar Drone merged with Bladeranger.
What is the typical investment stage for PipelBiz?
PipelBiz primarily invests in Seed and Pre-Seed stage companies, and also participates in A Round funding. A significant portion of their funding rounds, 64 in total, are through equity crowdfunding.
Who are the co-founders of PipelBiz?
PipelBiz was co-founded by Or Bennun, who serves as CEO, and Tom Seton, who is the CTO.
What is PipelBiz's investment range?
PipelBiz's investment range is between $41.49K and $8.5M.
Which of PipelBiz's portfolio companies went public recently?
NeuroSense Therapeutics went public on NASDAQ in December 2021, and Cannibble FoodTech went public on CSE in March 2022.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)